Follicular Dendritic Cell Sarcoma in an Adolescent Patient

BACKGROUND: Follicular dendritic cell sarcoma (FDCS) is a rare neoplasm that usually occurs in the adult population. Since its first description, only 9 cases have been reported in children. Due to its rarity, there is no standardized treatment. OBSERVATIONS: We present a case of multiply-relapsed FDCS in an adolescent patient that responded favorably to chemotherapy. CONCLUSION: For many, wide local excision of FDCS may be curative. However, more research is required to determine the best course of treatment for patients requiring adjuvant chemotherapy or radiation. In addition, expanding genetic research has the potential to provide targeted therapy in the future.

Authors

Institutions

Publication Details

Journal
Journal of Pediatric Hematology/Oncology
Published
2026-04-06
DOI
https://doi.org/10.1097/mph.0000000000003194
Primary Topic
Histiocytic Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Follicular Dendritic Cell Sarcoma in an Adolescent Patient

Allison Weisnicht, Darya Buehler, Tabassum A. Kennedy, Hannah Glanz et al.
Journal of Pediatric Hematology/Oncology
Histiocytic Disorders and Treatments
article

Follicular Dendritic Cell Sarcoma in an Adolescent Patient

Allison Weisnicht, Darya Buehler, Tabassum A. Kennedy, Hannah Glanz, Cathy Lee-Miller, Kristin Bradley, Jessica Gulliver
article en

Abstract

BACKGROUND: Follicular dendritic cell sarcoma (FDCS) is a rare neoplasm that usually occurs in the adult population. Since its first description, only 9 cases have been reported in children. Due to its rarity, there is no standardized treatment. OBSERVATIONS: We present a case of multiply-relapsed FDCS in an adolescent patient that responded favorably to chemotherapy. CONCLUSION: For many, wide local excision of FDCS may be curative. However, more research is required to determine the best course of treatment for patients requiring adjuvant chemotherapy or radiation. In addition, expanding genetic research has the potential to provide targeted therapy in the future.

Journal of Pediatric Hematology/OncologyVol. 48(4)
University of Wisconsin–Madison (US), University of Wisconsin Carbone Cancer Center (US)
Good health and well-being
Openalex Percentile: Top 27%
Histiocytic Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.